High-dose methylprednisolone pulse therapy during refractory COVID-19 acute respiratory distress syndrome: a retrospective observational study

High-dose methylprednisolone pulse therapy during refractory COVID-19 acute respiratory distress syndrome: a retrospective observational study

Abstract Background Current COVID-19 guidelines recommend the early use of systemic corticoids for COVID-19 acute respiratory distress syndrome (ARDS). It remains unknown if high-dose methylprednisolone pulse therapy (MPT) ameliorates refractory COVID-19 ARDS after many days of mechanical ventilatio...

Full description

Bibliographic Details
Main Authors: Carsten Zeiner, Malte Schröder, Selina Metzner, Johannes Herrmann, Quirin Notz, Sebastian Hottenrott, Daniel Röder, Patrick Meybohm, Philipp M. Lepper, Christopher Lotz
Format: Article
Language:English
Published: BMC 2023-10-01
Series:BMC Pulmonary Medicine
Subjects:
Corticoid
Methylprednisolone
Pulse therapy
SARS-CoV2
ECMO
Salvage Therapy
Online Access:https://doi.org/10.1186/s12890-023-02664-5

Internet

https://doi.org/10.1186/s12890-023-02664-5

Similar Items